quinidine has been researched along with cancidas in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, RB; Leake, BF; Lee, W; Lin, JH; Pearson, PG; Sandhu, P; Stone, JA; Xu, X; Yamazaki, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for quinidine and cancidas
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for quinidine and cancidas
Article | Year |
---|---|
Hepatic uptake of the novel antifungal agent caspofungin.
Topics: Adsorption; Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Caspofungin; Echinocandins; HeLa Cells; Humans; In Vitro Techniques; KB Cells; Kinetics; Lipopeptides; Liver; Liver-Specific Organic Anion Transporter 1; Peptides, Cyclic; Perfusion; Plasmids; Protein Binding; Rats; Receptors, Cell Surface; Tissue Distribution; Transfection | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |